Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
64,326,281
-
Total 13F shares
-
41,345,437
-
Share change
-
+2,843,017
-
Total reported value
-
$635,880,813
-
Put/Call ratio
-
487%
-
Price per share
-
$15.38
-
Number of holders
-
93
-
Value change
-
+$44,778,975
-
Number of buys
-
51
-
Number of sells
-
31
Institutional Holders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) as of Q4 2023
As of 31 Dec 2023,
Vera Therapeutics, Inc. - COMMON STOCK (VERA) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,345,437 shares.
The largest 10 holders included
COMMODORE CAPITAL LP, Kynam Capital Management, LP, Sofinnova Investments, Inc., FMR LLC, BlackRock Inc., Woodline Partners LP, STATE STREET CORP, Eversept Partners, LP, VANGUARD GROUP INC, and ORBIMED ADVISORS LLC.
This page lists
93
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.